Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Stock Short Interest Report for October

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the target of a large decline in short interest in the month of October. As of October 15th, there was short interest totaling 3,765 shares, a decline of 62.1% from the September 30th total of 9,931 shares. Based on an average trading volume of 37,922 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the shares of the company are short sold.

Institutional Trading of Invesco Pharmaceuticals ETF

A number of institutional investors have recently modified their holdings of PJP. Lodestone Wealth Management LLC bought a new stake in Invesco Pharmaceuticals ETF during the 3rd quarter valued at $25,000. Rockefeller Capital Management L.P. boosted its holdings in shares of Invesco Pharmaceuticals ETF by 20.5% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock worth $129,000 after acquiring an additional 209 shares during the period. Latitude Advisors LLC bought a new position in shares of Invesco Pharmaceuticals ETF in the third quarter worth $29,000. Geneos Wealth Management Inc. boosted its holdings in shares of Invesco Pharmaceuticals ETF by 24.2% in the first quarter. Geneos Wealth Management Inc. now owns 1,722 shares of the company’s stock worth $179,000 after acquiring an additional 335 shares during the period. Finally, Fifth Third Bancorp purchased a new position in shares of Invesco Pharmaceuticals ETF in the first quarter valued at $36,000.

Invesco Pharmaceuticals ETF Stock Performance

NYSEARCA PJP traded up $1.66 during trading on Friday, hitting $130.54. 52,087 shares of the company’s stock traded hands, compared to its average volume of 35,797. The stock has a market capitalization of $579.60 million, a price-to-earnings ratio of 15.59 and a beta of 0.44. Invesco Pharmaceuticals ETF has a 12-month low of $95.43 and a 12-month high of $131.88. The business has a 50 day moving average of $125.80 and a 200-day moving average of $114.46.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.